REQUEST A DEMO
Total
USD $0.00
Search more companies

Kontafarma China Holdings Limited (华控康泰集团有限公司) (Hong Kong SAR, China)

Main Activities: Cement and Concrete Product Manufacturing
Secondary Activities: Nonmetallic Mineral Mining and Quarrying
Full name: Kontafarma China Holdings Limited Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Kontafarma China Holdings Limited (华控康泰集团有限公司) is an enterprise based in Hong Kong SAR, China. Its main office is in Hong Kong. The company operates in the Cement and Concrete Product Manufacturing sector. It was incorporated on March 30, 2026. The total number of employees is currently 688 (2024). The latest financial highlights indicate a net sales revenue drop of 1.26% in Q2C2025. During that time, Kontafarma China Holdings Limited (华控康泰集团有限公司)’s total assets decreased by 31.85%. Kontafarma China Holdings Limited (华控康泰集团有限公司)’s net profit margin decreased by 70.01% in 2025.

Headquarters
15Th Floor, Allied Kajima Building, 138 Gloucester Road
Hong Kong; Hong Kong;

Contact Details: Purchase the Kontafarma China Holdings Limited (华控康泰集团有限公司) report to view the information.

Website: http://www.tfkf.com.hk

Basic Information
Total Employees:
Purchase the Kontafarma China Holdings Limited (华控康泰集团有限公司) report to view the information.
Outstanding Shares:
Purchase the Kontafarma China Holdings Limited (华控康泰集团有限公司) report to view the information.
Registered Capital:
Purchase the Kontafarma China Holdings Limited (华控康泰集团有限公司) report to view the information.
Financial Auditors:
Purchase the Kontafarma China Holdings Limited (华控康泰集团有限公司) report to view the information.
Incorporation Date:
March 30, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
56.77%
Purchase this report to view the information.
9.2%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Aii-Cement Limited (United Kingdom)
100%
Fortunate Gold Limited (United Kingdom)
100%
Sac Intellectual Properties Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Kontafarma China Holdings Limited (华控康泰集团有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.26%
Total Operating Revenue
-2.6%
Operating Profit
N/A
EBITDA
-42.48%
Net Profit/Loss for the Period
-6992.34%
Total Assets
-31.85%
Total Equity
-41.46%
Operating Profit Margin
N/A
Net Profit Margin
-70.01%
Return on Equity (ROE)
-51.34%
Debt / Equity
11151%
Quick Ratio
-441.02%
Cash Ratio
0.02%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?